Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Harefuah|February 20, 2002
[Somatization disorder in children and adolescents]Alona Gad, Gil Zalsman, Samuel Tyano
Harefuah|July 16, 2003
[Volatile substance abuse in children and adolescents]Eran Pickholtz, Gil Zalsman, Samuel Tyano
The Psychoanalytic Study of the Child|March 21, 2007
Some reflections on infancy-onset trichotillomaniaMiri Keren, Adi Ron-Miara, Ruth Feldman, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|May 7, 2024
Comparing the World Psychiatric Association and European Psychiatric Association Codes of Ethics: Discrepancies and shared groundsNoemi Sansone, Samuel Tyano, Antonio Melillo, et al.
Journal of Child and Adolescent Psychopharmacology|December 4, 2003
Effectiveness, safety, and tolerability of risperidone in adolescents with schizophrenia: an open-label studyGil Zalsman, Einat Carmon, Andrés Martin, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|April 27, 2004
Association of the dopamine D5 receptor with attention deficit hyperactivity disorder (ADHD) and scores on a continuous performance test (TOVA)Iris Manor, Marylis Corbex, Jacques Eisenberg, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|September 30, 2010
Association of polymorphisms of the serotonergic pathways with clinical traits of impulsive-aggression and suicidality in adolescents: a multi-center studyGil Zalsman, Miriam Patya, Amos Frisch, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 4, 2005
Plasma serotonin levels and suicidal behavior in adolescentsSamuel Tyano, Gil Zalsman, Hadas Ofek, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 6, 2003
DRD4 exon III polymorphism and response to risperidone in Israeli adolescents with schizophrenia: a pilot pharmacogenetic studyGil Zalsman, Amos Frisch, Shaul Lev-Ran, et al.
Pageof 1